These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 36352437)
1. Neoadjuvant versus adjuvant chemotherapy in upper tract urothelial carcinoma: A nationwide cohort study. Tae JH; Ha MS; Chi BH; Chang IH; Kim TH; Myung SC; Nguyen TT; Kim M; Lee KE; Kim Y; Woo HK; Kyoung DS; Kim H; Choi SY BMC Urol; 2022 Nov; 22(1):175. PubMed ID: 36352437 [TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy. Leow JJ; Chong YL; Chang SL; Valderrama BP; Powles T; Bellmunt J Eur Urol; 2021 May; 79(5):635-654. PubMed ID: 32798146 [TBL] [Abstract][Full Text] [Related]
3. Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study. Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Morita S; Kosaka T; Mizuno R; Arita Y; Akita H; Jinzaki M; Kikuchi E; Oya M Urol Oncol; 2022 Mar; 40(3):105.e19-105.e26. PubMed ID: 34454822 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy. Seisen T; Jamzadeh A; Leow JJ; Rouprêt M; Cole AP; Lipsitz SR; Kibel AS; Nguyen PL; Sun M; Menon M; Bellmunt J; Choueiri TK; Trinh QD JAMA Oncol; 2018 Feb; 4(2):225-229. PubMed ID: 28837718 [TBL] [Abstract][Full Text] [Related]
6. Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review. Aziz A; Dobruch J; Hendricksen K; Kluth LA; Necchi A; Noon A; Rink M; Roghmann F; Seiler R; Gontero P; Kassouf W; Shariat SF; Xylinas E; World J Urol; 2017 Sep; 35(9):1401-1407. PubMed ID: 28074261 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis. Quhal F; Mori K; Sari Motlagh R; Laukhtina E; Pradere B; Rouprêt M; Necchi A; Moschini M; Shariat SF Int J Clin Oncol; 2020 Jun; 25(6):1037-1054. PubMed ID: 32206939 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant Versus Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Microsimulation Model. Hird AE; Magee DE; Cheung DC; Sander B; Sridhar S; Nam RK; Kulkarni GS Clin Genitourin Cancer; 2021 Apr; 19(2):e135-e147. PubMed ID: 33168398 [TBL] [Abstract][Full Text] [Related]
10. Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical Chemotherapy in Patients With Upper Tract Urothelial Carcinomas Undergoing Minimally Invasive or Open Radical Nephroureterectomy: Analysis of US Claims on Perioperative Outcomes and Health Care Costs. Del Giudice F; van Uem S; Li S; Vilson FL; Sciarra A; Salciccia S; Busetto GM; Maggi M; Tiberia L; Viscuso P; Canale V; Panebianco V; Pecoraro M; Ferro M; Moschini M; Krajewski W; D'Andrea D; Cacciamani GE; Mari A; Soria F; Porpiglia F; Fiori C; Amparore D; Checcucci E; Autorino R; De Berardinis E; Chung BI Clin Genitourin Cancer; 2022 Apr; 20(2):198.e1-198.e9. PubMed ID: 35031226 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant Chemotherapy Benefits Survival in High-Grade Upper Tract Urothelial Carcinoma: A Propensity Score-Based Analysis. Chen L; Ou Z; Wang R; Zhang M; He W; Zhang J; Zu X; Yi L; Xu R; Jiang S; Qi L; Wang L Ann Surg Oncol; 2020 Apr; 27(4):1297-1303. PubMed ID: 31853757 [TBL] [Abstract][Full Text] [Related]
13. Association Between Perioperative Chemotherapy and Survival in Men Undergoing Radical Resection for Primary Urethral Urothelial Carcinoma: An Analysis of the National Cancer Database. Celtik K; Lim K; Dursun F; Xu J; Klaassen Z; Zhang J; Efstathiou E; Sonpavde G; Wallis C; Satkunasivam R Clin Genitourin Cancer; 2022 Jun; 20(3):244-251. PubMed ID: 35181268 [TBL] [Abstract][Full Text] [Related]
14. Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials. Bandini M; Briganti A; Plimack ER; Niegisch G; Yu EY; Bamias A; Agarwal N; Sridhar SS; Sternberg CN; Vaishampayan U; Théodore C; Rosenberg JE; Bellmunt J; Galsky MD; Montorsi F; Necchi A Eur Urol Oncol; 2019 May; 2(3):248-256. PubMed ID: 31200838 [TBL] [Abstract][Full Text] [Related]
16. Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis. Kim DK; Lee JY; Kim JW; Hah YS; Cho KS Crit Rev Oncol Hematol; 2019 Mar; 135():59-65. PubMed ID: 30819447 [TBL] [Abstract][Full Text] [Related]
17. Survival Outcomes in Neoadjuvant Chemotherapy for High-grade Upper Tract Urothelial Carcinoma: A Nationally Representative Analysis. Khan AI; Taylor BL; Al Hussein Al Awamlh B; Posada Calderon L; Fainberg J; Elahjji R; Shoag J; Scherr DS Urology; 2020 Dec; 146():158-167. PubMed ID: 32896584 [TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant versus adjuvant chemotherapy in bladder cancer: a nationwide cohort study. Choi SY; Ha MS; Chi BH; Kim JW; Chang IH; Kim TH; Myung SC; Kim M; Lee KE; Kim Y; Woo HK; Kyoung DS; Kim H J Cancer Res Clin Oncol; 2022 Nov; 148(11):3135-3144. PubMed ID: 35061097 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy increases survival and downstaging of upper tract urothelial cancer. Davaro F; May A; McFerrin C; Raza SJ; Siddiqui S; Hamilton Z Can J Urol; 2019 Oct; 26(5):9938-9944. PubMed ID: 31629443 [TBL] [Abstract][Full Text] [Related]